GI
ICPT

GAMCO Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

GAMCO Investors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,950
Closed -$555K – 876
2023
Q3 		$555K Buy
+29,950
New +$339K 0.01% 673

GAMCO Investors's ICPT Position: Q4 2023 in Review

GAMCO Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 29,950 shares — an estimated $555K sold.

GAMCO Investors first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $555K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • GAMCO Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • GAMCO Investors sold 29,950 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $555K.
  • GAMCO Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • GAMCO Investors's Intercept Pharmaceuticals, Inc. position peaked at $555K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on GAMCO Investors's 13F filing for Q4 2023, filed 14 Feb 2024.